Immunotherapy has a long history of use against cancer: in the 1890’s bacteria was injected into a tumour in an attempt to encourage a response by the immune system against the cancer.
EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet.
Read about the outcomes of our working policy breakfast in the European Parliament, hosted by MEPs Claudia Gamon and Tomislav Sokol, in cooperation with ARM, the Alliance for Regenerative Medicine.
A EuropaBio white paper calling for: equal assessment transparency; equal measures for traceability and adverse event reporting; and a level playing field for market access.